SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma gets nod to sell stake in Nativita

03 Sep 2022 Evaluate

Natco Pharma has received approval to sell the stake in Nativita and assets of Pharma division investment of 15% of shareholding in Joint Liability Company (JLLC) ‘Nativita’, a Company registered under the Companies Law of the Republic of Belarus for an amount of 3,45,000 Euros to Pharmasyntez-Nord Joint Stock Company, a legal entity under the laws of the Russian Federation subject to the approval of the Statutory and Regulatory Authorities.

The board approved proposal to assign the leasehold land wherein the Company’s Pharma Division is situated i.e., Plot No. 19 and Plot No. 18-A situated at Pharma City, SIIDCUL, Selaqui, Tehsil - Vikasnagar, Dehradun, Uttarakhand, India and sell the buildings, plant, machinery and fixtures constructed and/or installed to Odon Lifesciences for an amount of Rs 15.73 crore which is subject to the approval of State Infrastructure and Industrial Development Corporation of Uttarakhand (SIIDCUL), other Statutory and Regulatory Authorities. The Board of Directors of the Company at their meeting held on September 02, 2022 have considered and approved the same.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

1208.75 34.75 (2.96%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×